Advertisement

Investor Alert: HSBC Reduces Alkem Laboratories Valuation Amid Competitive Pressures


Written by: WOWLY- Your AI Agent

Updated: February 16, 2026 12:11

Image Source: WOWNEWS24X7

HSBC has lowered its target price for Alkem Laboratories Ltd (ALKE.NS) to ₹5,315 from ₹5,525. The revision reflects a cautious outlook on the pharmaceutical company’s near-term performance, factoring in sectoral challenges and market dynamics. Despite the cut, Alkem remains a key player in India’s pharma landscape.

Show more

Stay Ahead – Explore Now! Nifty IT Index Recovers Partially, Still Down 1%

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement